126 related articles for article (PubMed ID: 38554610)
1. Establishment of a novel canine soft tissue sarcoma cell line and comparison of its characteristics with other soft tissue sarcoma cell lines.
Miyanishi K; Igase M; Murakami M; Sakai Y; Sakurai M; Tani K; Motegi T; Mizuno T
Res Vet Sci; 2024 May; 171():105245. PubMed ID: 38554610
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a canine soft tissue sarcoma patient-derived xenograft model.
Frazier JP; Beirne E; Ditzler SH; Tretyak I; Casalini JR; Thirstrup DJ; Knoblaugh S; Ward JG; Tripp CD; Klinghoffer RA
Vet Comp Oncol; 2017 Sep; 15(3):754-763. PubMed ID: 26991424
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a canine soft tissue sarcoma cell line.
Snyder SA; Linder K; Hedan B; Hauck ML
Vet Pathol; 2011 Mar; 48(2):482-5. PubMed ID: 20974873
[TBL] [Abstract][Full Text] [Related]
4. Intra- and inter-observer agreement in histological assessment of canine soft tissue sarcoma.
Yap FW; Rasotto R; Priestnall SL; Parsons KJ; Stewart J
Vet Comp Oncol; 2017 Dec; 15(4):1553-1557. PubMed ID: 28133880
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of intratumoral microvessel density in canine soft-tissue sarcomas.
Luong RH; Baer KE; Craft DM; Ettinger SN; Scase TJ; Bergman PJ
Vet Pathol; 2006 Sep; 43(5):622-31. PubMed ID: 16966439
[TBL] [Abstract][Full Text] [Related]
6. Activation of the Akt signalling pathway as a prognostic indicator in canine soft tissue sarcoma.
Miyanishi K; Nururrozi A; Igase M; Tanabe M; Sakurai M; Sakai Y; Shimonohara N; Murakami M; Mizuno T
J Comp Pathol; 2023 Oct; 206():44-52. PubMed ID: 37839309
[TBL] [Abstract][Full Text] [Related]
7. A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies.
Takada M; Parys M; Gregory-Bryson E; Vilar Saavedra P; Kiupel M; Yuzbasiyan-Gurkan V
BMC Cancer; 2018 Mar; 18(1):237. PubMed ID: 29490634
[TBL] [Abstract][Full Text] [Related]
8. Canine Cutaneous and Subcutaneous Soft Tissue Sarcoma: An Evidence-Based Review of Case Management.
Hohenhaus AE; Kelsey JL; Haddad J; Barber L; Palmisano M; Farrelly J; Soucy A
J Am Anim Hosp Assoc; 2016; 52(2):77-89. PubMed ID: 26808432
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor blockade in combination with conventional chemotherapy inhibits soft tissue sarcoma cell growth in vitro and in vivo.
Ren W; Korchin B; Zhu QS; Wei C; Dicker A; Heymach J; Lazar A; Pollock RE; Lev D
Clin Cancer Res; 2008 May; 14(9):2785-95. PubMed ID: 18451246
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma.
Stevenson VB; Gudenschwager-Basso EK; Klahn S; LeRoith T; Huckle WR
Vet Comp Oncol; 2023 Dec; 21(4):709-716. PubMed ID: 37680007
[TBL] [Abstract][Full Text] [Related]
11. Animal models of Soft Tissue Sarcoma for alternative anticancer therapy studies: characterization of the A-72 Canine Cell Line.
Razzuoli E; Chirullo B; De Ciucis CG; Mecocci S; Martini I; Zoccola R; Campanella C; Varello K; Petrucci P; Di Meo A; Bozzetta E; Tarantino M; Goria M; Modesto P
Vet Res Commun; 2023 Sep; 47(3):1615-1627. PubMed ID: 37038001
[TBL] [Abstract][Full Text] [Related]
12. Soft tissue sarcomas.
Mauldin GN
Vet Clin North Am Small Anim Pract; 1997 Jan; 27(1):139-48. PubMed ID: 9002173
[TBL] [Abstract][Full Text] [Related]
13. Influence of surgical margin completeness on risk of local tumour recurrence in canine cutaneous and subcutaneous soft tissue sarcoma: A systematic review and meta-analysis.
Milovancev M; Tuohy JL; Townsend KL; Irvin VL
Vet Comp Oncol; 2019 Sep; 17(3):354-364. PubMed ID: 30953384
[TBL] [Abstract][Full Text] [Related]
14. Grade shifts in recurrent canine soft tissue sarcomas and mast cell tumors.
Griffin MA; Hughes K; Altwal J; Seguin B; Wustefeld-Janssens B
J Am Vet Med Assoc; 2023 Sep; 261(9):1-8. PubMed ID: 37257826
[TBL] [Abstract][Full Text] [Related]
15. Correlation between cytologic features and histologic grades in cutaneous and subcutaneous soft tissue sarcomas in dogs-A pilot study.
Sanchez-Redondo S; Hare CHZ; Constantino-Casas F; Williams TL
Vet Clin Pathol; 2021 Jun; 50(2):236-239. PubMed ID: 33797110
[TBL] [Abstract][Full Text] [Related]
16. A Novel Imaging System Distinguishes Neoplastic from Normal Tissue During Resection of Soft Tissue Sarcomas and Mast Cell Tumors in Dogs.
Bartholf DeWitt S; Eward WC; Eward CA; Lazarides AL; Whitley MJ; Ferrer JM; Brigman BE; Kirsch DG; Berg J
Vet Surg; 2016 Aug; 45(6):715-22. PubMed ID: 27281113
[TBL] [Abstract][Full Text] [Related]
17. Low-dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma.
Burton JH; Mitchell L; Thamm DH; Dow SW; Biller BJ
J Vet Intern Med; 2011; 25(4):920-6. PubMed ID: 21736624
[TBL] [Abstract][Full Text] [Related]
18. Molecular signatures of BRCAness analysis identifies PARP inhibitor Niraparib as a novel targeted therapeutic strategy for soft tissue Sarcomas.
Li H; Tu J; Zhao Z; Chen L; Qu Y; Li H; Yao H; Wang X; Lee DF; Shen J; Wen L; Huang G; Xie X
Theranostics; 2020; 10(21):9477-9494. PubMed ID: 32863940
[No Abstract] [Full Text] [Related]
19. Medical management of soft tissue sarcomas.
Rassnick KM
Vet Clin North Am Small Anim Pract; 2003 May; 33(3):517-31. PubMed ID: 12852234
[TBL] [Abstract][Full Text] [Related]
20. Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach.
Wei Q; Ramsey SA; Larson MK; Berlow NE; Ochola D; Shiprack C; Kashyap A; Séguin B; Keller C; Löhr CV
BMC Cancer; 2019 Apr; 19(1):311. PubMed ID: 30947707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
